{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:02Z","timestamp":1792785842131,"version":"4.5.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"10","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tuberculosis Epidemiologic Studies Consortium"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tuberculosis (TB) elimination within the United States will require scaling up TB preventive services. Many public health departments offer care for latent tuberculosis infection (LTBI), although gaps in the LTBI care cascade are not well quantified. An understanding of these gaps will be required to design targeted public health interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cohort study through the Tuberculosis Epidemiologic Studies Consortium (TBESC) within 15 local health department (LHD) TB clinics across the United States. Data were abstracted on individuals receiving LTBI care during 2016\u20132017 through chart review. Our primary objective was to quantify the LTBI care cascade, beginning with LTBI testing and extending through treatment completion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 23 885 participants tested by LHDs, 46% (11 009) were male with a median age of 31 (interquartile range [IQR] 20\u201346). A median of 35% of participants were US-born at each site (IQR 11\u201378). Overall, 16 689 (70%) received a tuberculin skin test (TST), 6993 (29%) received a Quantiferon (QFT), and 1934 (8%) received a T-SPOT.TB; 5% (1190) had more than one test. Among those tested, 2877 (12%) had at least one positive test result (3% among US-born, and 23% among non-US\u2013born, P\u2005&amp;lt;\u2005.01). Of 2515 (11%) of the total participants diagnosed with LTBI, 1073 (42%) initiated therapy, of whom 817 (76%) completed treatment (32% of those with LTBI diagnosis).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Significant gaps were identified along the LTBI care cascade, with less than half of individuals diagnosed with LTBI initiating therapy. Further research is needed to better characterize the factors impeding LTBI diagnosis, treatment initiation, and treatment completion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciac248","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T07:29:50Z","timestamp":1648538990000},"page":"1792-1799","source":"Crossref","is-referenced-by-count":39,"title":["Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States"],"prefix":"10.1093","volume":"75","author":[{"given":"Samuel B","family":"Holzman","sequence":"first","affiliation":[{"name":"Division of Epidemiology, Department of Population Health, New York University School of Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Perry","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Population Health, New York University School of Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Saleeb","sequence":"additional","affiliation":[{"name":"Maryland Department of Health and Hygiene , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pyan","sequence":"additional","affiliation":[{"name":"Maryland Department of Health and Hygiene , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Keh","sequence":"additional","affiliation":[{"name":"Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Tuberculosis Control Branch , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Salcedo","sequence":"additional","affiliation":[{"name":"Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Tuberculosis Control Branch , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Narita","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Disease and Immunology, Levine Children\u2019s Hospital , Charlotte, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaddeus L","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Health Behavior and Health Systems, University of North Texas Health Science Center , Fort Worth, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April C","family":"Pettit","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Vanderbilt University Medical Center , Nashville, Tennessee , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Khurana","sequence":"additional","affiliation":[{"name":"Maricopa County Department of Public Health , Phoenix, Arizona , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Whipple","sequence":"additional","affiliation":[{"name":"Northrop Grumman , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly","family":"Katz","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Largen","sequence":"additional","affiliation":[{"name":"Hawaii Department of Health , Honolulu, Hawaii , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Krueger","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maunank","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Population Health, New York University School of Medicine , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Tuberculosis Epidemiologic Studies Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"2022111415390553700_CIT0001","volume-title":"A call for action on the tuberculosis elimination plan for the Unites States","author":"Stop TB USA.","year":"2010"},{"key":"2022111415390553700_CIT0002","author":"Centers for Disease Control and Prevention."},{"key":"2022111415390553700_CIT0003","author":"CDC."},{"key":"2022111415390553700_CIT0004","author":"CDC.","year":"2019"},{"key":"2022111415390553700_CIT0005","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection.","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"2022111415390553700_CIT0006","doi-asserted-by":"crossref","first-page":"e0153728","DOI":"10.1371\/journal.pone.0153728","article-title":"Recent transmission of tuberculosis - United States, 2011\u20132014.","volume":"11","author":"Yuen","year":"2016","journal-title":"PLoS One"},{"key":"2022111415390553700_CIT0007","doi-asserted-by":"crossref","first-page":"295","DOI":"10.15585\/mmwr.mm6611a3","article-title":"Tuberculosis among foreign-born persons diagnosed &gt;\/=10 years after arrival in the United States, 2010\u20132015.","volume":"66","author":"Tsang","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022111415390553700_CIT0008","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons.","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2022111415390553700_CIT0009","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S095026881100286X","article-title":"Modelling tuberculosis trends in the USA.","volume":"140","author":"Hill","year":"2012","journal-title":"Epidemiol Infect"},{"key":"2022111415390553700_CIT0010","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(15)00323-2","article-title":"Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.","volume":"386","author":"Rangaka","year":"2015","journal-title":"Lancet"},{"key":"2022111415390553700_CIT0011","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/aje\/kwy094","article-title":"Prospects for tuberculosis elimination in the United States: results of a transmission dynamic model.","volume":"187","author":"Menzies","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2022111415390553700_CIT0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6901a1","article-title":"Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020.","volume":"69","author":"Sterling","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2022111415390553700_CIT0013","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/rccm.201508-1683OC","article-title":"The prevalence of latent tuberculosis infection in the United States.","volume":"194","author":"Mancuso","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2022111415390553700_CIT0014","doi-asserted-by":"crossref","first-page":"e0140881","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: prevalence estimates from the National Health and Nutrition Examination Survey, 2011\u20132012.","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"key":"2022111415390553700_CIT0015","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/thoraxjnl-2018-211715","article-title":"Evaluating latent tuberculosis infection diagnostics using latent class analysis.","volume":"73","author":"Stout","year":"2018","journal-title":"Thorax"},{"key":"2022111415390553700_CIT0016","doi-asserted-by":"crossref","first-page":"257","DOI":"10.15585\/mmwr.mm6811a2","article-title":"Tuberculosis - United States, 2018.","volume":"68","author":"Talwar","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2022111415390553700_CIT0017","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada.","volume":"137","author":"Horsburgh","year":"2010","journal-title":"Chest"},{"key":"2022111415390553700_CIT0018","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection.","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"2022111415390553700_CIT0019","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis.","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2022111415390553700_CIT0020","doi-asserted-by":"crossref","first-page":"e0180707","DOI":"10.1371\/journal.pone.0180707","article-title":"Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: a systematic review.","volume":"12","author":"Malekinejad","year":"2017","journal-title":"PLoS One"},{"key":"2022111415390553700_CIT0021","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in Adults and Children.","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022111415390553700_CIT0022","volume-title":"A guide for health care providers and public health programs: testing and treatment of latent tuberculosis infection in the United States: clinical recommendations.","author":"National Society of Tuberculosis Clinicians and National Tuberculosis Controllers Association.","year":"2021"},{"key":"2022111415390553700_CIT0023","author":"CDC."},{"key":"2022111415390553700_CIT0024","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: US preventive services task force recommendation statement.","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"2022111415390553700_CIT0025","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1513\/AnnalsATS.202009-1153OC","article-title":"Self-reported engagement in care among U.S. residents with latent tuberculosis infection: 2011\u20132012.","volume":"18","author":"Mancuso","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2022111415390553700_CIT0026","author":"CDC."},{"key":"2022111415390553700_CIT0027","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/archinte.166.17.1863","article-title":"Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.","volume":"166","author":"Page","year":"2006","journal-title":"Arch Intern Med"},{"key":"2022111415390553700_CIT0028","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10903-020-01047-w","article-title":"Programmatic effectiveness of latent tuberculosis care cascade in a community health center.","volume":"23","author":"Prater","year":"2020","journal-title":"J Immigr Minor Health"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac248\/43862684\/ciac248.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/10\/1792\/47029374\/ciac248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/10\/1792\/47029374\/ciac248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T12:48:03Z","timestamp":1668430083000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/10\/1792\/6562172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,4,1]]},"published-print":{"date-parts":[[2022,11,14]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac248","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,15]]},"published":{"date-parts":[[2022,4,1]]}}}